Nano Mobile Healthcare, Inc. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance Sheets

In millions of USD, except per-share amounts

	Q1 FY2016 As of Sep 30, 2016	Q4 FY2015 As of Jun 30, 2016	Q3 FY2015 As of Mar 31, 2016	Q4 FY2014 As of Jun 30, 2015	Q2 FY2014 As of Dec 31, 2014	Q1 FY2014 As of Sep 30, 2014	Q3 FY2013 As of Mar 31, 2014	Q2 FY2013 As of Dec 31, 2013	Q1 FY2013 As of Sep 30, 2013	Q4 FY2012 As of Jun 30, 2013	Q3 FY2012 As of Mar 31, 2013	Q2 FY2012 As of Dec 31, 2012	Q1 FY2012 As of Sep 30, 2012	Q2 FY2011 As of Dec 31, 2011
ASSETS
Current assets
Cash and cash equivalents
Accounts receivable
Interest receivable
Prepaid expenses
Prepaid expenses and other current assets
Total current assets

Property and equipment, net
Note receivable - related party
Fixed Assets
Securities - available for sale

Assets of discontinued operations
Securities-available for sale
Total assets
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities
Accounts payable and accrued liabilities

Shareholder loans
Convertible notes payable, net
Shareholder loans
Liabilities of discontinued operations
Convertible notes payable
Due to related parties
Derivative liabilities
Total current liabilities
Convertible debt
Total liabilities
Stockholders' deficit
Preferred stock; $0.001 par value; 50,000,000 shares authorized; 23,473,368 shares issued and outstanding as of September 30, 2016 and June 30, 2016, respectively
Common stock; $0.001 par value; 900,000,000 shares authorized; 512,825,018 shares issued and outstanding as of September 30, 2016 and 227,331,108 as of June 30, 2016, respectively
Additional paid-in capital
Stock subscription receivable
Deferred stock-based compensation
Accumulated other comprehensive income (loss)
Deficit accumulated during the development stage
Total Vantage Health equity
Non-controlling interest
Accumulated deficit
Total stockholders' deficit

Total liabilities and stockholders' deficit

Comments